AML-MRMDSAMLacute myeloid leukaemia
…y. Furthermore, 44% of AML with KMT2A-PTD could be diagnosed as AML-MR based on cytogenetics or genomics. We observed progenitor abnor…
37articles mentioning diseases
184disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: AML ×
AML
This disease is selected. Its supporting articles are shown below.
Articles mentioning AML
37 articles · page 2 of 4AMLhematologic malignanciesCG1xCD3 TCE
…me limitations of conventional bispecific TCEs, particularly in AML patients with high disease burden, thus supporting clinical exp…
acute myeloid leukaemiaAMLHospital Anxiety and Depression ScaleEPC
…anges in quality of life (QOL) and symptoms among patients with acute myeloid leukaemia (AML) receiving real-world early palliative care (EPC) during t…
acute myeloid leukaemiaAMLoestrogenchemotherapy
…The spread of acute myeloid leukaemia (AML) outside of the blood or bone marrow is known as extramedu…
AMLacute myeloid leukemia
…R-pHLA complex (PDB: 2BNQ), we substituted the peptide with the AML neoantigen and used ProteinMPNN, a deep learning-based protein …
Breast cancerColon cancerLung cancerAcute myeloid leukemia
…ticularly in oncology. Clinically validated examples include: • Breast cancer: The Oncotype DX test analyzes 21-gene expression in hormone re…
acute myeloid leukaemiaMyeloid neoplasmsMDSAMLmyelodysplastic neoplasmsChemotherapynational MN registry
…angements can present either myelodysplastic neoplasms (MDS) or acute myeloid leukaemia (AML), both associated with dismal prognosis. The 2022 WHO clas…
multiple myelomaacute myeloid leukemiaMDSCD1d-expressing hematological malignanciesAMLMMlenalidomideIMiD
… cells to CD1d-expressing hematological malignancies, including multiple myeloma (MM) and acute myeloid leukemia (AML). Here, we evaluated wheth…
AMLacute myeloid leukemiaschronic myelomonocytic leukemiaTCMCMMLT-cell malignanciesIndiana UniversityFDAbendamustinefludarabine/cyclophosphamide+2 more
…aded by CTCAE v5.0.Results Fourteen patients were treated: CD4+ AML (n=2), CMML (n=3), and TCM (n=9). Median age was 65.5 years (ra…
AMLanti-pan γδ x CD123 bispecific antibodyanti-pan γδ x CD123
…and may provide a safer and more effective treatment option for AML.Reference Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Ki…
AMLinduction therapy
…-TAD2 variants, TAD2 variants were associated with older age at AML onset (40 years vs 21 years, p<0.001), a higher burden of coope…